Amedisys Inc (STU:ADY)
€ 87 0 (0%) Market Cap: 2.90 Bil Enterprise Value: 3.24 Bil PE Ratio: 0 PB Ratio: 2.87 GF Score: 85/100

Amedisys Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2023 / 01:15AM GMT
Release Date Price: €77 (+1.32%)
Unidentified Analyst

Hello, everyone, and welcome to the 41st Annual JPMorgan Healthcare Conference. It is my pleasure to introduce the next presenting company, Amedisys, and CEO, Paul Kusserow.

Paul Berthold Kusserow
Amedisys, Inc. - Chairman & CEO

Perfect. Thanks, [Alex]. Good afternoon, everyone. Thank you for your patience. I know there's -- I'm the only thing between you and the bar at this point, so I'll make it to the point. Pleasure to be here and wanted to talk to you about some of the -- one of the things you always come up with at JPMorgan is the timing. So you don't talk about earnings. So you talk about strategy. So I wanted to make sure that we went through some slides in terms of strategy, and then we'll be obviously coming out with our earnings later in the month.

But I wanted to talk about some of the large demographic things that are actually occurring that I'm finding that, and we're finding as a company, that are quite significant. And that is there's a tsunami that's starting to build up in terms of the population. If you see the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot